Facilitated By

San Antonio Medical Foundation

News

  • Ibrance combination extends median PFS in breast cancer group | The Pharmaletter

    12 December 2024. More on this story... Pfizer's rollercoaster ride and what comes next · Biotechnology.

  • ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...

    ... biotechnology company advancing therapies that ... The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer ...

  • Holland & Knight Expands Intellectual Property Group with Addition of Partner Kenneth ...

    His practice covers various industries, including biotech ... degree in physiology from The University of Texas Health Science Center at San Antonio and ...

  • US appeals court rejects Nasdaq's diversity rules for company boards

    Brooklynn Chandler Willy, CEO and president of San Antonio-based Texas Financial Advisory,. Business · IRS arrests S.A. investment adviser, radio host ...

  • Stirista Climbs to #4 on San Antonio Business Journal's 2024 Fast Track Awards

    Biotechnology · Clinical Trials & Medical Discoveries · Dentistry · FDA ... San Antonio Business Journal's Fast Track Awards for 2024. This marks ...